Department of Pediatric Pneumology, Immunology and Intensive Care Medicine, Charité Medical University, Berlin, Germany.
Department of Pediatrics, Pediatric Allergy Unit, Sandro Pertini Hospital, Rome, Italy.
Pediatr Allergy Immunol. 2020 Feb;31 Suppl 24:61-64. doi: 10.1111/pai.13165.
Mobile health is the "medical and public health practice supported by mobile devices, such as mobile phones, patient monitoring devices, personal digital assistants, and other wireless devices." For example, mobile apps (such as MASK-Air, Allergy.Monitor, Pollen, and others) have proven useful in the management of patients with allergic rhinitis. These apps can be used in the context of broader clinical decision support systems (CDSS) for enhancing allergy-related decisions and actions with pertinent, organized clinical knowledge and patient information to improve allergy care. A CDSS targeted to control rhinitis with drugs and other interventions guiding the patient in his/her self- and doctor-driven management is currently being produced and investigated by the MACVIA network. Another one, called @IT-2020, is targeted to support etiologic diagnostics and allergen immunotherapy (AIT) prescriptions for patients with seasonal allergic rhinitis. Intensive investigation is necessary to better define the advantages and limitations of mobile-health technology in allergology and establish guidelines for their proper use in daily practice in the context of a rapidly evolving European regulatory environment.
移动医疗是指“通过移动设备（如手机、患者监测设备、个人数字助理和其他无线设备）支持的医学和公共卫生实践”。例如，移动应用程序（如 MASK-Air、Allergy.Monitor、Pollen 等）已被证明在过敏性鼻炎患者的管理中非常有用。这些应用程序可以在更广泛的临床决策支持系统（CDSS）中使用，以利用相关、有组织的临床知识和患者信息来增强与过敏相关的决策和行动，从而改善过敏护理。MACVIA 网络目前正在开发和研究一种针对药物控制鼻炎和其他干预措施的 CDSS，以指导患者进行自我和医生驱动的管理。另一个名为@IT-2020 的 CDSS 则旨在支持季节性过敏性鼻炎患者的病因诊断和变应原免疫治疗（AIT）处方。需要进行深入研究，以更好地定义移动医疗技术在过敏学中的优势和局限性，并在快速发展的欧洲监管环境下，为其在日常实践中的正确使用制定指南。
